Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | OPN-6602 |
Trade Name | |
Synonyms | OPN6602|OPN 6602 |
Drug Descriptions |
OPN-6602 is a small molecule inhibitor of EP300 (p300) and CBP (CREBBP), which downregulates IRF4 and MYC, potentially inhibiting tumor growth (Cancer Res (2024) 84 (6_Supplement): 660). |
DrugClasses | CBP/p300 inhibitor 13 |
CAS Registry Number | |
NCIT ID |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Dexamethasone + OPN-6602 | Dexamethasone OPN-6602 | 0 | 1 |
Lenalidomide + OPN-6602 | Lenalidomide OPN-6602 | 0 | 0 |
OPN-6602 | OPN-6602 | 0 | 1 |